跳至主要内容
临床试验/JPRN-UMIN000021878
JPRN-UMIN000021878已完成未知

Development and validation of the novel recurrence risk stratification for initial non-muscle invasive bladder cancer - Development and validation of the novel recurrence risk stratification for initial non-muscle invasive bladder cancer

Juntendo University, Graduate School of Medicine0 个研究点目标入组 856 人开始时间: 2016年4月12日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
856

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
23years-old 至 99years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients with any of the following were excluded from this analysis: (i) non-Urothelial carcinoma histology, (ii) follow-up periods < 3 months: (iii) history of muscle-invasive or metastatic bladder cancer; (iv) history of carcinoma of the urethra, prostate (ducts or stroma), or upper urinary tract; (v) history of local radiation therapy to the pelvis; (vi) history of every kind of chemotherapy; (vii) history of previous bacillus Calmette-Guerin (BCG) therapy.

研究者

发起方
Juntendo University, Graduate School of Medicine

相似试验